OR52N3P

Across TCGA pan-cancer cohorts, OR52N3P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of OR52N3P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR52N3P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR52N3P is over-expressed in tumor, although a few such as BRCA and LUSC show the opposite, repressed pattern.

KIRC, BRCA, and LUSC are the cancer types where OR52N3P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52N3P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	III,IV	+0.040	.006	6	view →
BRCA	All	II,III,IV	−0.065	.006	4	view →
LUSC	All	All	−0.085	.001	3	view →
KICH	Female	II,III,IV	−0.054	.027	3	view →
PAAD	Female	All	−0.145	.010	2	view →
LUAD	Female	All	−0.033	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

OR52N3P–KIRC

Open the KIRC breakdown →